Toxigenic Clostridium difficile colonization in children

Abstract Clostridium difficile is a Gram positive, spore-forming organism that has become a significant cause of nosocomial infection in hospitalized adults. Colonization with this organism results in a wide spectrum of clinical conditions, including an asymptomatic carrier state, mild self-limited diarrhea, pseudomembranous colitis, and fulminant colitis. It’s role in disease in children remains controversial. This is a prospective study in which we evaluated all the patients hospitalized in the infectious diseases ward of Mofid Children’s Hospital, Tehran during 12 months (between September 2006 and September 2007). Stool samples from 250 patients were cultured for C. difficile and specimens analyzed for detection of toxin A and B. Data were analyzed by SPSS software version 11.5. Stool culture was positive for C. difficile in 113 (45.2%) patients, 10 (4%) of these were positive for both toxins A and B by enzyme-linked immunosorbent assay (ELISA). ELISA was negative in all patients with negative culture. None of the variables tested (age and antibiotic exposure) was significantly correlated with colonization. This is the first study about colonization rates of C. difficile in children in Iran. We conclude that although the C. difficile colonization rate in our children is high (45.2%), the rate of toxigenic strains is low (4%). This may explain the low rate of C. difficile associated disease (CACD) in our population.

[1]  Joseph M. Campos,et al.  Changing Epidemiology of Clostridium difficile-Associated Disease in Children , 2007, Infection Control & Hospital Epidemiology.

[2]  Stuart H. Cohen,et al.  Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center. , 2006, Diagnostic microbiology and infectious disease.

[3]  T. Karasawa,et al.  Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. , 2005, International microbiology : the official journal of the Spanish Society for Microbiology.

[4]  M. Delmée,et al.  Heterogeneity ofClostridium difficile isolates from infants , 1993, European Journal of Pediatrics.

[5]  D. Decré,et al.  Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile , 2004, Journal of Clinical Microbiology.

[6]  J. Colaert,et al.  Significance of Clostridium difficile and its cytotoxin in children , 1986, European Journal of Pediatrics.

[7]  S. Guandalini,et al.  Pediatric Clostridium difficile: A Phantom Menace or Clinical Reality? , 2000, Journal of pediatric gastroenterology and nutrition.

[8]  J. Conly,et al.  Clostridium difficile-associated diarrhea - the new scourge of the health care facility. , 2000, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[9]  G. Nicholson,et al.  Laboratory assessment of five enzyme immunoassay Clostridium difficile toxin detection kits. , 1999, British journal of biomedical science.

[10]  D. Gerding,et al.  Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.

[11]  H. Applebaum,et al.  Perforated pseudomembranous colitis in the breast-fed infant. , 1992, Journal of pediatric surgery.

[12]  L. Rosen,et al.  Clostridium difficile—A common and costly colitis , 1991, Diseases of the colon and rectum.

[13]  T. Wilkins,et al.  Clostridium difficile: its disease and toxins , 1988, Clinical Microbiology Reviews.

[14]  H. Malamou-Ladas,et al.  Isolation of Clostridium difficile from patients and the environment of hospital wards. , 1983, Journal of clinical pathology.